cAMP-associated inhibition of phenobarbital-inducible cytochrome P450 gene expression in primary rat hepatocyte cultures

J. S. Sidhu, Curtis John Omiecinski

Research output: Contribution to journalArticle

96 Citations (Scopus)

Abstract

The effects of elevated intracellular cyclic adenosine monophosphate (cAMP) in regulating phenobarbital (PB)-inducible gene expression in primary rat hepatocyte cultures were investigated. Cells were exposed to various concentrations (0.1-100 μM) of cAMP analogs and/or activators of intracellular cAMP-dependent pathways. Effects of these treatments were assessed either using a 1-h pulse prior to PB (100 μM) exposure or in conjunction with PB during a 24-h exposure period. PB-inducible responses were measured in hepatocytes by hybridization to cytochrome P450 (CYP) CYP2B1, CYP2B2, and CYP3A1 mRNAs. The cAMP analogs, 8-bromo-cAMP, 8-(4- chlorophenylthio)-cAMP, dibutyryl cAMP,and (Sp)-5,6-DCI-cBiMPS ((S(p))-5,6- dichloro-1-β-D-ribofuranosylbenzimidazole-3',5'-monophosphorothioate), and the activators of adenylate cyclase, forskolin and glucagon, dramatically inhibited PB-mediated induction of CYP2B1 and CYP2B2 in a concentration- dependent manner. A similar inhibition of PB-induced CYP3A1 mRNA levels was effected by the cAMP analogs and glucagon. The phosphodiesterase inhibitors isobutylmethylxanthine and RO 201724 potentiated the cAMP responses. Increasing the concentration of PB (0.05-1.00 mM) did not alleviate the cAMP- mediated repression. A requirement for protein kinase A (PKA) was demonstrated by the use of (S(p))-cAMPS, a highly specific activator of PKA, whereas the inactive diastereoisomer, (R(p))-cAMPS, was ineffective in modulating PB induction. The response to cAMP was specific since elevated intracellular cAMP levels did not perturb β-naphtholflavone-mediated induction of CYP1A1, CYP1A2, microsomal epoxide hydrolase, or dexamethasone- mediated induction of CYP3A1 gene expression. Nor did elevated intracellular cAMP modulate the liver-selective albumin gene expression levels. The results of the present study demonstrated striking inhibition of PB-mediated CYP gene induction by cAMP and PKA activators, indicating a negative regulatory role for the cAMP signal transduction pathway on PB gene induction.

Original languageEnglish (US)
Pages (from-to)12762-12773
Number of pages12
JournalJournal of Biological Chemistry
Volume270
Issue number21
DOIs
StatePublished - Jan 1 1995

Fingerprint

Phenobarbital
Gene expression
Cyclic AMP
Cytochrome P-450 Enzyme System
Rats
Hepatocytes
Gene Expression
Cyclic AMP-Dependent Protein Kinases
Cytochrome P-450 CYP2B1
Glucagon
Adenosine Kinase
Genes
8-Bromo Cyclic Adenosine Monophosphate
Epoxide Hydrolases
Cytochrome P-450 CYP1A2
Messenger RNA
Cytochrome P-450 CYP1A1
Phosphodiesterase Inhibitors
Signal transduction
Colforsin

All Science Journal Classification (ASJC) codes

  • Biochemistry

Cite this

@article{8a5de3cfd9dc4803a843864d74a1f84a,
title = "cAMP-associated inhibition of phenobarbital-inducible cytochrome P450 gene expression in primary rat hepatocyte cultures",
abstract = "The effects of elevated intracellular cyclic adenosine monophosphate (cAMP) in regulating phenobarbital (PB)-inducible gene expression in primary rat hepatocyte cultures were investigated. Cells were exposed to various concentrations (0.1-100 μM) of cAMP analogs and/or activators of intracellular cAMP-dependent pathways. Effects of these treatments were assessed either using a 1-h pulse prior to PB (100 μM) exposure or in conjunction with PB during a 24-h exposure period. PB-inducible responses were measured in hepatocytes by hybridization to cytochrome P450 (CYP) CYP2B1, CYP2B2, and CYP3A1 mRNAs. The cAMP analogs, 8-bromo-cAMP, 8-(4- chlorophenylthio)-cAMP, dibutyryl cAMP,and (Sp)-5,6-DCI-cBiMPS ((S(p))-5,6- dichloro-1-β-D-ribofuranosylbenzimidazole-3',5'-monophosphorothioate), and the activators of adenylate cyclase, forskolin and glucagon, dramatically inhibited PB-mediated induction of CYP2B1 and CYP2B2 in a concentration- dependent manner. A similar inhibition of PB-induced CYP3A1 mRNA levels was effected by the cAMP analogs and glucagon. The phosphodiesterase inhibitors isobutylmethylxanthine and RO 201724 potentiated the cAMP responses. Increasing the concentration of PB (0.05-1.00 mM) did not alleviate the cAMP- mediated repression. A requirement for protein kinase A (PKA) was demonstrated by the use of (S(p))-cAMPS, a highly specific activator of PKA, whereas the inactive diastereoisomer, (R(p))-cAMPS, was ineffective in modulating PB induction. The response to cAMP was specific since elevated intracellular cAMP levels did not perturb β-naphtholflavone-mediated induction of CYP1A1, CYP1A2, microsomal epoxide hydrolase, or dexamethasone- mediated induction of CYP3A1 gene expression. Nor did elevated intracellular cAMP modulate the liver-selective albumin gene expression levels. The results of the present study demonstrated striking inhibition of PB-mediated CYP gene induction by cAMP and PKA activators, indicating a negative regulatory role for the cAMP signal transduction pathway on PB gene induction.",
author = "Sidhu, {J. S.} and Omiecinski, {Curtis John}",
year = "1995",
month = "1",
day = "1",
doi = "10.1074/jbc.270.21.12762",
language = "English (US)",
volume = "270",
pages = "12762--12773",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "21",

}

cAMP-associated inhibition of phenobarbital-inducible cytochrome P450 gene expression in primary rat hepatocyte cultures. / Sidhu, J. S.; Omiecinski, Curtis John.

In: Journal of Biological Chemistry, Vol. 270, No. 21, 01.01.1995, p. 12762-12773.

Research output: Contribution to journalArticle

TY - JOUR

T1 - cAMP-associated inhibition of phenobarbital-inducible cytochrome P450 gene expression in primary rat hepatocyte cultures

AU - Sidhu, J. S.

AU - Omiecinski, Curtis John

PY - 1995/1/1

Y1 - 1995/1/1

N2 - The effects of elevated intracellular cyclic adenosine monophosphate (cAMP) in regulating phenobarbital (PB)-inducible gene expression in primary rat hepatocyte cultures were investigated. Cells were exposed to various concentrations (0.1-100 μM) of cAMP analogs and/or activators of intracellular cAMP-dependent pathways. Effects of these treatments were assessed either using a 1-h pulse prior to PB (100 μM) exposure or in conjunction with PB during a 24-h exposure period. PB-inducible responses were measured in hepatocytes by hybridization to cytochrome P450 (CYP) CYP2B1, CYP2B2, and CYP3A1 mRNAs. The cAMP analogs, 8-bromo-cAMP, 8-(4- chlorophenylthio)-cAMP, dibutyryl cAMP,and (Sp)-5,6-DCI-cBiMPS ((S(p))-5,6- dichloro-1-β-D-ribofuranosylbenzimidazole-3',5'-monophosphorothioate), and the activators of adenylate cyclase, forskolin and glucagon, dramatically inhibited PB-mediated induction of CYP2B1 and CYP2B2 in a concentration- dependent manner. A similar inhibition of PB-induced CYP3A1 mRNA levels was effected by the cAMP analogs and glucagon. The phosphodiesterase inhibitors isobutylmethylxanthine and RO 201724 potentiated the cAMP responses. Increasing the concentration of PB (0.05-1.00 mM) did not alleviate the cAMP- mediated repression. A requirement for protein kinase A (PKA) was demonstrated by the use of (S(p))-cAMPS, a highly specific activator of PKA, whereas the inactive diastereoisomer, (R(p))-cAMPS, was ineffective in modulating PB induction. The response to cAMP was specific since elevated intracellular cAMP levels did not perturb β-naphtholflavone-mediated induction of CYP1A1, CYP1A2, microsomal epoxide hydrolase, or dexamethasone- mediated induction of CYP3A1 gene expression. Nor did elevated intracellular cAMP modulate the liver-selective albumin gene expression levels. The results of the present study demonstrated striking inhibition of PB-mediated CYP gene induction by cAMP and PKA activators, indicating a negative regulatory role for the cAMP signal transduction pathway on PB gene induction.

AB - The effects of elevated intracellular cyclic adenosine monophosphate (cAMP) in regulating phenobarbital (PB)-inducible gene expression in primary rat hepatocyte cultures were investigated. Cells were exposed to various concentrations (0.1-100 μM) of cAMP analogs and/or activators of intracellular cAMP-dependent pathways. Effects of these treatments were assessed either using a 1-h pulse prior to PB (100 μM) exposure or in conjunction with PB during a 24-h exposure period. PB-inducible responses were measured in hepatocytes by hybridization to cytochrome P450 (CYP) CYP2B1, CYP2B2, and CYP3A1 mRNAs. The cAMP analogs, 8-bromo-cAMP, 8-(4- chlorophenylthio)-cAMP, dibutyryl cAMP,and (Sp)-5,6-DCI-cBiMPS ((S(p))-5,6- dichloro-1-β-D-ribofuranosylbenzimidazole-3',5'-monophosphorothioate), and the activators of adenylate cyclase, forskolin and glucagon, dramatically inhibited PB-mediated induction of CYP2B1 and CYP2B2 in a concentration- dependent manner. A similar inhibition of PB-induced CYP3A1 mRNA levels was effected by the cAMP analogs and glucagon. The phosphodiesterase inhibitors isobutylmethylxanthine and RO 201724 potentiated the cAMP responses. Increasing the concentration of PB (0.05-1.00 mM) did not alleviate the cAMP- mediated repression. A requirement for protein kinase A (PKA) was demonstrated by the use of (S(p))-cAMPS, a highly specific activator of PKA, whereas the inactive diastereoisomer, (R(p))-cAMPS, was ineffective in modulating PB induction. The response to cAMP was specific since elevated intracellular cAMP levels did not perturb β-naphtholflavone-mediated induction of CYP1A1, CYP1A2, microsomal epoxide hydrolase, or dexamethasone- mediated induction of CYP3A1 gene expression. Nor did elevated intracellular cAMP modulate the liver-selective albumin gene expression levels. The results of the present study demonstrated striking inhibition of PB-mediated CYP gene induction by cAMP and PKA activators, indicating a negative regulatory role for the cAMP signal transduction pathway on PB gene induction.

UR - http://www.scopus.com/inward/record.url?scp=0029068165&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029068165&partnerID=8YFLogxK

U2 - 10.1074/jbc.270.21.12762

DO - 10.1074/jbc.270.21.12762

M3 - Article

VL - 270

SP - 12762

EP - 12773

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 21

ER -